Header Logo

Kimberly Lenz

Concepts (82)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
341
0.730
Why?
Analgesics, Opioid
4
2019
495
0.610
Why?
Pain
3
2019
405
0.580
Why?
Medication Therapy Management
3
2018
25
0.400
Why?
Antiviral Agents
3
2018
314
0.340
Why?
Practice Patterns, Physicians'
5
2019
715
0.320
Why?
Hepatitis C
2
2016
139
0.230
Why?
United States
10
2019
7520
0.180
Why?
Drug Utilization Review
2
2017
56
0.170
Why?
Chloride Channel Agonists
1
2019
3
0.170
Why?
Aminophenols
1
2019
4
0.170
Why?
Drug and Narcotic Control
2
2017
30
0.170
Why?
Benzodioxoles
1
2019
13
0.170
Why?
Aminopyridines
1
2019
23
0.170
Why?
Quinolones
1
2019
27
0.160
Why?
Cystic Fibrosis
1
2019
108
0.150
Why?
Uridine Monophosphate
1
2018
8
0.150
Why?
Fluorenes
1
2018
13
0.150
Why?
Medication Adherence
2
2017
254
0.150
Why?
Benzimidazoles
1
2018
59
0.150
Why?
Psychotropic Drugs
1
2018
83
0.150
Why?
Insurance, Pharmaceutical Services
2
2014
24
0.140
Why?
Hydrocodone
1
2017
6
0.140
Why?
Hepatitis C, Chronic
1
2018
88
0.140
Why?
Opioid-Related Disorders
2
2014
465
0.140
Why?
Hepacivirus
1
2018
140
0.140
Why?
Drug Prescriptions
1
2018
189
0.140
Why?
Progesterone
1
2017
157
0.140
Why?
Premature Birth
1
2017
108
0.130
Why?
Lung
1
2019
833
0.120
Why?
Prescription Drug Diversion
1
2014
7
0.120
Why?
State Government
1
2014
32
0.110
Why?
Prescription Drug Misuse
1
2014
22
0.110
Why?
Drug Combinations
3
2019
137
0.110
Why?
Drug Interactions
1
2014
113
0.110
Why?
Managed Care Programs
1
2014
94
0.110
Why?
Retrospective Studies
7
2018
6008
0.110
Why?
Health Services Accessibility
1
2016
541
0.090
Why?
Mental Disorders
1
2018
765
0.090
Why?
Treatment Outcome
3
2016
5174
0.080
Why?
Young Adult
4
2019
4322
0.080
Why?
Adolescent
4
2019
5917
0.070
Why?
Adult
6
2019
15770
0.070
Why?
Humans
10
2019
59476
0.070
Why?
Drug Costs
2
2016
59
0.060
Why?
Cost Savings
2
2016
56
0.060
Why?
Female
7
2019
30896
0.060
Why?
Cost-Benefit Analysis
2
2017
299
0.060
Why?
Middle Aged
5
2019
16260
0.060
Why?
Pharmacists
2
2016
123
0.060
Why?
Program Evaluation
2
2018
485
0.060
Why?
Male
6
2019
27562
0.050
Why?
Massachusetts
2
2018
2095
0.050
Why?
Cohort Studies
2
2017
2443
0.040
Why?
Child
2
2019
4308
0.040
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
75
0.040
Why?
Sustained Virologic Response
1
2018
10
0.040
Why?
Sofosbuvir
1
2018
18
0.040
Why?
Ribavirin
1
2018
24
0.040
Why?
Polypharmacy
1
2018
62
0.040
Why?
Treatment Failure
1
2018
188
0.040
Why?
Hydroxyprogesterones
1
2017
6
0.040
Why?
Controlled Substances
1
2017
5
0.040
Why?
Viral Load
1
2018
229
0.040
Why?
Dose-Response Relationship, Drug
1
2019
796
0.030
Why?
Drug Therapy, Combination
1
2018
432
0.030
Why?
RNA, Viral
1
2018
264
0.030
Why?
Gestational Age
1
2017
183
0.030
Why?
Psychiatry
1
2018
129
0.030
Why?
Genotype
1
2018
637
0.030
Why?
Insurance Claim Review
1
2016
80
0.030
Why?
Evidence-Based Medicine
1
2018
454
0.030
Why?
Pregnancy Outcome
1
2017
188
0.030
Why?
Government Regulation
1
2014
44
0.030
Why?
Interdisciplinary Communication
1
2014
107
0.030
Why?
Physician's Role
1
2014
120
0.030
Why?
Cooperative Behavior
1
2014
220
0.030
Why?
Health Policy
1
2014
185
0.030
Why?
Mutation
1
2019
2445
0.020
Why?
Pregnancy
1
2017
2355
0.020
Why?
Time Factors
1
2014
3578
0.020
Why?
Aged
1
2018
13343
0.010
Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_